Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of PAC-14028 Cream for seborrheic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• PAC-14028 cream (PAC-14028)

Snippet

Sponsor: Amorepacific Corporation | Conditions: Seborrheic Dermatitis | Phase 2 | Status: COMPLETED